
Avalon GloboCare Corp.
Avalon GloboCare Corp. (Nasdaq: ALBT) is a biotechnology company dedicated to develop and deliver innovative and transformative technologies, precision diagnostics and intellectual property.
Nasdaq: AVCO
IR Website: https://ir.avalon-globocare.com/
Headquarters: Freehold, NJ
To get the full story on Avalon GloboCare, please click on this link.
TALK TO MANAGEMENT
The Avalon Globocare management team is always available to talk to current and potential investors. They're happy to answer any questions you may have and tell you what makes their story unique. Please fill out this form, and we will connect you shortly.
Summary

To get the full story on Avalon GloboCare, please click on this link..
Founded in 2016 as an OTCQB company, Avalon GloboCare successfully uplisted to NASDAQ in December 2018. It currently has partnerships with two major universities that focus on refinement, applications and production, and a skin care company to advance product commercialization with Avalon’s ACTEX™ platform. Underpinning Avalon’s R&D pipeline is a broad and deep intellectual property portfolio, covering a number of key enabling technologies and addressing multi-billion dollars of unmet market worldwide. The company has approximately 20 full time employees at its headquarters in Freehold, NJ and its subsidiaries.
• Purchased headquarters building in Freehold/New Jersey in 2017 (USD $8M), which generates average annual revenue of USD $1.2M
• Successfully filed for USD $50M mixed shelf offering (S3) in January 2019
• Chairman provided USD $20M credit facility, enabling acceleration of R&D
• Shares outstanding: 82M
Video: Bezinga Presents an Interview with Avalon GloboCare

Press Release / Library
Investor Presentation

To download the Avalon GloboCare investor presentation, please fill out the form below.
Stock Chart
Stock Detail
SEC Filings
Exosomes and AVCO

Avalon GloboCare has partnered with HydroPeptide, a skin-care company, in order to to accelerate AVCO's ACTEX™ product development and commercialization, thus demonstrating the potential flexibility of their capabilities.
Current Candidates

Strategic Partnerships

Senior Management

David Jin, M.D., Ph.D.
Chief Executive Officer, President
Luisa Ingargiola
Chief Financial Officer
Meng Li
Chief Operating Officer
Daniel Lu
Chairman of the Board
Risks & Disclosures

This communication is neither an offer to sell nor a solicitation of an offer to buy, nor a recommendation of any securities of the company mentioned herein.
Avalon GloboCare, Corp. (the “Company”) and its counsel have reviewed the content of this page as well as the accompanying presentation (“Company Presentation”) displayed on this page. To the best of its knowledge, the Company does not believe this content to be misleading or inaccurate in any material respect, nor does it believe there are any material omissions with respect to such content. The Company does not believe the contents of the page or the Company Presentation to contain any non-public material information.
Information and opinions presented in the Company Presentation are provided by the Company, and b2i Digital makes no representation as to their accuracy or completeness. The information contained on this page is not intended to constitute any form of advice, and the information provided is not intended to provide a sufficient basis on which to make an investment decision. It is not investment research, nor does it constitute a research recommendation, as it does not constitute substantive research or analysis. This information is not to be relied upon in substitution for the exercise of independent judgment.
Information, opinions and estimates contained on this page or in the Company Presentation reflect judgments by the Company as of the original date of publication by the Company and are subject to change without notice. Past performance should not be taken as an indication or guarantee of future performance, and no representation or warranty, express or implied is made regarding future performance.
A complete description of the risks and uncertainties relating to the Company and its securities can be found in the company's filings with the U.S. Securities and Exchange Commission available for free at www.sec.gov.
Information on this page may relate to penny stocks, which may also be referred to as low-priced stocks. Penny stocks are low-priced shares typically issued by small companies. Penny stocks involve greater than normal risk, they may be less liquid than other stocks (i.e., more difficult to sell), and there may be less reliable information available regarding such stocks. Investors in penny stocks should be prepared for the possibility that they may lose their entire investment.
b2i Digital or its related entities may own securities of the Company.
To comply with Rule 17(b) of the Securities Act of 1933, as amended, b2i Digital must provide full disclosure of all compensation received for investor awareness services provided by the Company.
The Company is a client of b2i Digital. The Company agreed to pay b2i Digital no greater than $100,000 in cash for 12 months of digital marketing consulting and investor awareness services.
The Avalon GloboCare Corp. management and investor relations team is available to talk to current and potential investors. They're happy to answer your questions and tell you what makes their story unique. Please fill out this form, and we will connect you shortly.
• Directly hear the Avalon GloboCare Corp. story
• Ask your questions
• Submit the form below and someone will get in touch with you as soon as possible
Note: Company management or its representative can only discuss and disclose information that is already available in the public domain. They will do their best to clarify such information to the extent permitted by securities law and industry regulations.